Literature DB >> 25150782

Interleukin-8 promotes cell migration through integrin αvβ6 upregulation in colorectal cancer.

Qi Sun1, Fengkai Sun2, Ben Wang1, Song Liu3, Weibo Niu4, Enyu Liu4, Cheng Peng4, Jiayong Wang4, Huijie Gao1, Benjia Liang1, Zhengchuan Niu1, Xueqing Zou1, Jun Niu5.   

Abstract

Colorectal cancer (CRC), which is notorious for high morbidity and mortality around the world, shows a predilection for metastasis to liver. Interleukin-8 (IL-8), a chemokine with a defining CXC amino acid motif, has been reported to promote CRC cell migration and is associated with poor prognosis of CRC. However, the underlying molecular mechanism of IL-8-mediated migration remains obscure. In this study, we first demonstrated the cross talk between IL-8 and integrin αvβ6. We analyzed 139 human CRC samples, and found that the immunohistochemical expression of αvβ6 was significantly correlated with expression of IL-8. Furthermore, IL-8 increased the migration through integrin αvβ6 in human CRC cells, and both CXCR1 and CXCR2 were primarily involved during the process. IL-8 upregulated αvβ6 expression in a dose-dependent manner through activation of ERK and Ets-1 signaling pathway. Taken together, our results indicated that IL-8 enhances the migration of CRC cells by increasing αvβ6 integrin expression through the ERK/Ets-1 pathway. Targeting integrin αvβ6 in IL-8 expressing tumors might be a potential therapeutic strategy for CRC patients.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Integrin αvβ6; Interleukin-8; Migration

Mesh:

Substances:

Year:  2014        PMID: 25150782     DOI: 10.1016/j.canlet.2014.08.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  29 in total

1.  Integrin β6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy.

Authors:  Liu Enyu; Niu Zhengchuan; Wang Jiayong; Liang Benjia; Sun Qi; Qin Ruixi; Peng Cheng; Abdul Qadir Khan; Song Wei; Niu Jun
Journal:  Tumour Biol       Date:  2015-05-17

2.  Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.

Authors:  Qi Sun; Fanni Li; Fengkai Sun; Jun Niu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

3.  A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.

Authors:  Sadia Mahboob; Seong Beom Ahn; Harish R Cheruku; David Cantor; Emma Rennel; Simon Fredriksson; Gabriella Edfeldt; Edmond J Breen; Alamgir Khan; Abidali Mohamedali; Md Golam Muktadir; Shoba Ranganathan; Sock-Hwee Tan; Edouard Nice; Mark S Baker
Journal:  Clin Proteomics       Date:  2015-04-08       Impact factor: 3.988

4.  Common Effects on Cancer Cells Exerted by a Random Positioning Machine and a 2D Clinostat.

Authors:  Benjamin Svejgaard; Markus Wehland; Xiao Ma; Sascha Kopp; Jayashree Sahana; Elisabeth Warnke; Ganna Aleshcheva; Ruth Hemmersbach; Jens Hauslage; Jirka Grosse; Johann Bauer; Thomas Juhl Corydon; Tawhidul Islam; Manfred Infanger; Daniela Grimm
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.

Authors:  Wei Li; Ying Zhou; Jin Yang; Xu Zhang; Huanhuan Zhang; Ting Zhang; Shaolin Zhao; Ping Zheng; Juan Huo; Huiyi Wu
Journal:  J Exp Clin Cancer Res       Date:  2015-05-20

6.  GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.

Authors:  Mingo Ming-Ho Yung; Hermit Wai-Man Tang; Patty Chun-Hui Cai; Thomas Ho-Yin Leung; Siew-Fei Ngu; Karen Kar-Loen Chan; Dakang Xu; Huijuan Yang; Hextan Yuen-Sheung Ngan; David Wai Chan
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

7.  Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.

Authors:  Darius Wlochowitz; Martin Haubrock; Jetcy Arackal; Annalen Bleckmann; Alexander Wolff; Tim Beißbarth; Edgar Wingender; Mehmet Gültas
Journal:  Front Genet       Date:  2016-04-05       Impact factor: 4.599

8.  Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma.

Authors:  Zequn Li; Siddhartha Biswas; Benjia Liang; Xueqing Zou; Liqun Shan; Yang Li; Ruliang Fang; Jun Niu
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

9.  Colorectal cancer-promoting activity of the senescent peritoneal mesothelium.

Authors:  Justyna Mikuła-Pietrasik; Patrycja Sosińska; Konstantin Maksin; Mał Gorzata Kucińska; Hanna Piotrowska; Marek Murias; Aldona Woźniak; Dariusz Szpurek; Krzysztof Książek
Journal:  Oncotarget       Date:  2015-10-06

10.  Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Authors:  Naomi O Hodgins; Wafa' T Al-Jamal; Julie T-W Wang; Rebecca Klippstein; Pedro M Costa; Jane K Sosabowski; John F Marshall; John Maher; Khuloud T Al-Jamal
Journal:  J Control Release       Date:  2017-04-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.